Celgene Corporation and bluebird bio Announce bb2121 Anti-BCMA CAR-T Cell Therapy Has Been Granted Breakthrough Therapy Designation from FDA and Prime Eligibility from EMA for Relapsed and Refractory Multiple Myeloma Life Science
Tencent poised to rub shoulders with Apple and Facebook as China’s first entrant to the elite ‘US$500b tech club’ Life Science